SEARCH RESULT

Total Matching Records found : 1463

Novartis order may force pharma MNCs to change

-The Economic Times Foreign pharma companies could be forced to overhaul their strategy for the Indian market by striking more local deals and cutting sky-high drug prices after the Supreme Court slammed the door on Swiss giant Novartis' attempts to gain a patent for its blood cancer-busting drug Glivec. But the ruling, welcomed by activists campaigning for affordable drugs and local generic companies, threatened to reinforce a narrative that India...

More »

Supreme Court's Glivec ruling will ruin innovation

-The Economic Times Extension of life is priceless. Simply priceless." These were the words of Venkat Krishnan (name changed) to Novartis after receiving treatment with Glivec for about two years. Following his diagnosis with chronic myeloid leukaemia (CML), Venkat married his college sweetheart against the wishes of her family. After all, the prognosis in those days for people suffering from CML was not promising. Taking interferon, a powerful immune therapy, was the...

More »

Sticky food inflation a combination of fiscal indiscipline, rural wages, global factors -Sanjeeb Mukherjee

-The Business Standard Ashok Gulati in a paper also gave measures to contain the inflation As India's food inflation continues to remain stubbornly high - it was in double digit for the third straight month in February 2013 at 11.38% - a discussion paper floated by eminent agriculture economist and chairman of Commission for Agriculture Costs and Prices (CACP) Ashok Gulati has blamed high fiscal deficit, rising farm wages and global food...

More »

SC verdict on Novartis AG plea today

-Reuters Global drugmakers, battered by recent intellectual property decisions in the country, are girding for a landmark court ruling on Monday with broad consequences for their ability to sell lucrative patented medicines in the country. Supreme Court is due to decide on April 1 whether or not Swiss giant Novartis AG's cancer treatment Glivec deserves a patent in the country. "Big Pharma is nervous because nothing has gone in their favour in the...

More »

Cash transfer of subsidy could save Rs 60,000 crore: Study -Surojit Gupta

-The Times of India Direct transfer of benefits in cash to targeted beneficiaries of food and fertilizer subsidies could save an estimated Rs 60,000 cr and help trim the fiscal deficit which, in turn, may calm stubbornly high food inflation, a study by a government wing has shown. The study showed that policies to rein in food inflation would require winding down of the fiscal deficit, which has gone above 8% of...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close